The Beijing Economic-Technological Development Area (Beijing E-Town) recently held a business exchange event for foreign-funded enterprises, which attracted over 20 enterprises, including Biotech Pharma, AstraZeneca and Pall China, as well as multiple financial institutions to participate.

Aiming to deepen cooperation with foreign-funded enterprises and explore their capital needs and development opportunities, the event invited experts to interpret the Beijing Foreign Investment Regulations enacted this year; officials from the Bureau of Commerce and Finance to introduce the preferential interest policies in the Beijing E-Town; a senior analyst to delve into the future trends of the exchange rate market; and officials from Beijing E-Town Capital to introduce international financing channels for local enterprises and related services for expanding into the Middle East market.

"Beijing E-Town places great importance on the foreign investment environment, providing enterprises with quality services such as policy subsidies and financial platforms. They deliver policy interpretations directly to entrepreneurs, helping companies fully benefit from policy dividends. With a first-class business environment and thoughtful support services, enterprises have confidence and more motivation for development," said Liu Linrui, the administrative manager of Biotech Pharma.

As an important gateway for the capital's opening-up to the outside world and a crucial engine for economic development, Beijing E-Town has always been committed to providing foreign-funded enterprises with a high-quality business environment and comprehensive service support. Going forward, Beijing E-Town intends to build itself into a fertile terrain for foreign enterprises to invest and thrive in, and a model of win-win cooperation between Chinese and foreign companies.